However, IL-17-producing tumor-infiltrating cells in patients with esophageal squamous cell carcinoma (ESCC) may play a protective role in the tumor microenvironment and can be used as a prognostic marker for ESCC patients. Here, IL17A is linked to esophageal squamous cell carcinoma.